MONTRÉAL, Aug. 31, 2021 /PRNewswire/ - CellCarta and Olink Proteomics AB announced today a strategic collaboration to offer Olink® Target 96 & Target 48 to pharmaceutical and biotech customers, ...
Uppsala, Sweden, March 29, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that the regional proteomic facility, D-CYPHR in Cape Town, South Africa has adopted Olink ...
UPPSALA, Sweden, July 12, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (OLK) today announced the introduction of Olink ® Explore HT, a transformational solution for high-throughput proteomics ...
UPPSALA, Sweden, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that Novogene Asia Pacific Middle East and Africa (AMEA) has adopted the Olink ...
HUNTSVILLE, Ala., Sept. 20, 2022 /PRNewswire/ -- Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, has entered into an agreement with Olink Holding AB (publ) (Olink) ...
Uppsala, Sweden, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Eurofins Genomics adopts Olink (OLK) ® technology to advance proteomics research and accelerate precision medicine programs UPPSALA, Sweden, 12 th ...
Olink Genomics offers Selector Technology as a service and through an early access program for customized kits. Karolinska Institutet researchers are to use Olink Genomics’ Selector Technology™ for ...